ArticleFrontiers in physiology2016

The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia.

Ernie D Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.